133 related articles for article (PubMed ID: 2420730)
1. Isoprinosine abolishes the blocking factor-mediated inhibition of lymphocyte responses to Epstein-Barr virus antigens and phytohemagglutinin.
Sundar SK; Menezes J
Int J Immunopharmacol; 1986; 8(1):101-6. PubMed ID: 2420730
[TBL] [Abstract][Full Text] [Related]
2. Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens.
Sundar SK; Barile G; Menezes J
Int J Immunopharmacol; 1985; 7(2):187-92. PubMed ID: 2409036
[TBL] [Abstract][Full Text] [Related]
3. IgG from Epstein-Barr virus infectious mononucleosis patients inhibits interleukin-2 production.
Sundar SK; Stefanescu I; Menezes J
Int J Immunopharmacol; 1987; 9(8):869-73. PubMed ID: 3501412
[TBL] [Abstract][Full Text] [Related]
4. Inosiplex enhances the growth of Epstein-Barr nuclear antigen-positive B-cells from patients with rheumatoid arthritis and infectious mononucleosis.
Becker H; Helmke K
Int J Immunopharmacol; 1988; 10(4):439-43. PubMed ID: 2459076
[TBL] [Abstract][Full Text] [Related]
5. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
Morin A; Griscelli C; Daguillard F
Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
[TBL] [Abstract][Full Text] [Related]
6. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.
Wiranowska-Stewart M; Hadden JW
Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734
[TBL] [Abstract][Full Text] [Related]
7. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
[TBL] [Abstract][Full Text] [Related]
8. Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen.
Ballet JJ; Morin A; Schmitt C; Agrapart M
Int J Immunopharmacol; 1982; 4(3):151-7. PubMed ID: 6179890
[TBL] [Abstract][Full Text] [Related]
9. The effect of isoprinosine on the PHA response of monocyte-depleted and undepleted peripheral blood mononuclear cells.
Jacobsen PL; Greenspan JS
J Immunopharmacol; 1982-1983; 4(4):355-65. PubMed ID: 6192176
[TBL] [Abstract][Full Text] [Related]
10. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
11. Influence of isoprinosine on lymphocyte function in virus-infected feeder pigs.
Flaming KP; Blecha F; Fedorka-Cray PJ; Anderson GA
Am J Vet Res; 1989 Oct; 50(10):1653-7. PubMed ID: 2478051
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of isoprinosine on lymphocyte proliferation: comparison of two tissue culture media.
Cabrera EJ; Sergio SL
Int J Immunopharmacol; 1986; 8(8):893-6. PubMed ID: 2433235
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.
Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ
Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598
[TBL] [Abstract][Full Text] [Related]
15. Isoprinosine: an overview.
Simon LN; Glasky AJ
Cancer Treat Rep; 1978 Nov; 62(11):1963-9. PubMed ID: 83189
[TBL] [Abstract][Full Text] [Related]
16. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
17. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
[TBL] [Abstract][Full Text] [Related]
18. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.
Hadden JW; Hadden EM; Coffey RG
Infect Immun; 1976 Feb; 13(2):382-7. PubMed ID: 57100
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of cell-mediated immunity by a serum blocking factor isolated from patients with infectious mononucleosis.
Wainwright WH; Veltri RW; Sprinkle PM
J Infect Dis; 1979 Jul; 140(1):22-32. PubMed ID: 88489
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
